Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population

AIMS: The aim was to study the efficacy of combined therapy with reduced-fluence photodynamic therapy (RFPDT) and intravitreal bevacizumab/ranibizumab from the Indian subcontinent. SETTINGS AND DESIGN: This was a single-center, retrospective interventional study. METHODS: Thirty-five eyes of 34 pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Ophthalmol
Autors principals: Sen, Parveen, Bhende, Muna, Sachidanandam, Ramya, Bansal, Nishat, Sharma, Tarun
Format: Artigo
Idioma:Inglês
Publicat: Medknow Publications & Media Pvt Ltd 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5322706/
https://ncbi.nlm.nih.gov/pubmed/28112132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.198856
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars